天臣医疗
(688013)
| 流通市值：25.73亿 | | | 总市值：25.73亿 |
| 流通股本：8115.56万 | | | 总股本：8115.56万 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 55,677,592.99 | 326,733,883.44 | 243,831,328.07 | 156,168,251.45 |
| 营业收入 | 55,677,592.99 | 326,733,883.44 | 243,831,328.07 | 156,168,251.45 |
| 二、营业总成本 | 52,954,345.86 | 243,879,907.75 | 170,220,030.83 | 107,096,608.2 |
| 营业成本 | 19,971,705.32 | 117,872,581.77 | 89,678,738.36 | 57,727,624.59 |
| 税金及附加 | 519,591.41 | 3,066,938.84 | 2,325,447.85 | 1,315,134.65 |
| 销售费用 | 9,688,586.06 | 47,672,256.37 | 34,030,842.7 | 22,251,588.29 |
| 管理费用 | 7,881,425.09 | 34,095,466.4 | 26,247,313.99 | 17,728,352.65 |
| 研发费用 | 12,848,086.66 | 51,302,319.64 | 28,808,026.79 | 18,896,254.85 |
| 财务费用 | 2,044,951.32 | -10,129,655.27 | -10,870,338.86 | -10,822,346.83 |
| 其中:利息费用 | 226,538.75 | 473,452.33 | 245,940.32 | 133,416.79 |
| 其中:利息收入 | 8,273.66 | 103,381.31 | 77,336.17 | 65,515.8 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 140,987.45 | 8,476,382.03 | 2,678,920.36 | 1,669,079.24 |
| 加:投资收益 | 5,867,694.33 | 2,768,145.01 | 2,555,956.48 | 2,346,670.95 |
| 资产处置收益 | 49,379.92 | 409,429.03 | 686.5 | 686.5 |
| 资产减值损失(新) | -253,480 | -186,605.72 | -263,291.52 | -281,134.21 |
| 信用减值损失(新) | 487,445.17 | -1,611,627 | -732,542 | -829,195.13 |
| 其他收益 | 596,864.98 | 2,902,503.56 | 1,626,330.26 | 1,167,019.08 |
| 四、营业利润 | 9,612,138.98 | 95,612,202.6 | 79,477,357.32 | 53,144,769.68 |
| 加:营业外收入 | - | 44,369.78 | 974,288.43 | 119,307.28 |
| 减:营业外支出 | 291.02 | 489,577.35 | 94,978.46 | 93,908.34 |
| 五、利润总额 | 9,611,847.96 | 95,166,995.03 | 80,356,667.29 | 53,170,168.62 |
| 减:所得税费用 | -81,120.84 | 9,981,570.99 | 8,410,916.93 | 4,958,594.53 |
| 六、净利润 | 9,692,968.8 | 85,185,424.04 | 71,945,750.36 | 48,211,574.09 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 9,692,968.8 | 85,185,424.04 | 71,945,750.36 | 48,211,574.09 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 9,692,968.8 | 85,185,424.04 | 71,945,750.36 | 48,211,574.09 |
| 扣除非经常损益后的净利润 | 4,109,050.45 | 74,235,859.47 | 66,202,274.94 | 44,286,432.99 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.12 | 1.06 | 0.9 | 0.6 |
| (二)稀释每股收益 | 0.12 | 1.05 | 0.89 | 0.59 |
| 八、其他综合收益 | 241,582.49 | -41,346.61 | -41,971.49 | -390,775.6 |
| 归属于母公司股东的其他综合收益 | 241,582.49 | -41,346.61 | -41,971.49 | -390,775.6 |
| 九、综合收益总额 | 9,934,551.29 | 85,144,077.43 | 71,903,778.87 | 47,820,798.49 |
| 归属于母公司股东的综合收益总额 | 9,934,551.29 | 85,144,077.43 | 71,903,778.87 | 47,820,798.49 |
| 公告日期 | 2026-04-29 | 2026-04-29 | 2025-10-24 | 2025-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |